Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Development of an mRNA vaccine against Crimean-Congo haemorrhagic fever virus
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (VIVAC research group)
2025 (English)Independent thesis Advanced level (degree of Master (Two Years)), 30 credits / 45 HE creditsStudent thesis
Place, publisher, year, edition, pages
2025.
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-560155OAI: oai:DiVA.org:uu-560155DiVA, id: diva2:1970975
External cooperation
Karolinska Institutet
Subject / course
Drug Development
Educational program
Master's Programme in Biopharmaceuticals
Supervisors
Examiners
Available from: 2025-06-18 Created: 2025-06-17 Last updated: 2025-06-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Pharmacy
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 184 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.49.0
|
WCAG
|
Uppsala University Library
|
Ask the Library
|
Log in to DiVA
|
Search and link in DiVA